Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS

Flora Tassone, C. M. Greco, M. R. Hunsaker, A. L. Seritan, Robert F Berman, L. W. Gane, S. Jacquemont, K. Basuta, Lee-Way Jin, Paul J Hagerman, Randi J Hagerman

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder associated with premutation alleles of the fragile X mental retardation 1 (FMR1) gene. Approximately 40% of older male premutation carriers, and a smaller proportion of females, are affected by FXTAS; due to the lower penetrance the characterization of the disorder in females is much less detailed. Core clinical features of FXTAS include intention tremor, cerebellar gait ataxia and frequently parkinsonism, autonomic dysfunction and cognitive deficits progressing to dementia in up to 50% of males. In this study, we report the clinical, molecular and neuropathological findings of eight female premutation carriers. Significantly, four of these women had dementia; of the four, three had FXTAS plus dementia. Post-mortem examination showed the presence of intranuclear inclusions in all eight cases, which included one asymptomatic premutation carrier who died from cancer. Among the four subjects with dementia, three had sufficient number of cortical amyloid plaques and neurofibrillary tangles to make Alzheimer's disease a highly likely cause of dementia and a fourth case had dementia with cortical Lewy bodies. Dementia appears to be more common than originally reported in females with FXTAS. Although further studies are required, our observation suggests that in a portion of FXTAS cases there is Alzheimer pathology and perhaps a synergistic effect on the progression of the disease may occur.

Original languageEnglish (US)
Pages (from-to)577-585
Number of pages9
JournalGenes, Brain and Behavior
Volume11
Issue number5
DOIs
StatePublished - Jul 2012

Fingerprint

Clinical Pathology
Molecular Pathology
Dementia
Gait Ataxia
Lewy Bodies
Intranuclear Inclusion Bodies
Neurofibrillary Tangles
Penetrance
Amyloid Plaques
Parkinsonian Disorders
Tremor
Fragile X Tremor Ataxia Syndrome
Intellectual Disability
Neurodegenerative Diseases
Disease Progression
Autopsy
Alzheimer Disease
Alleles
Observation
Pathology

Keywords

  • Activation ratio
  • Alzheimer disease
  • FMR1 premutation
  • FXTAS
  • RNA toxicity

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Genetics
  • Neurology

Cite this

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. / Tassone, Flora; Greco, C. M.; Hunsaker, M. R.; Seritan, A. L.; Berman, Robert F; Gane, L. W.; Jacquemont, S.; Basuta, K.; Jin, Lee-Way; Hagerman, Paul J; Hagerman, Randi J.

In: Genes, Brain and Behavior, Vol. 11, No. 5, 07.2012, p. 577-585.

Research output: Contribution to journalArticle

@article{67c7d56b8fed424f845213357c267e18,
title = "Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS",
abstract = "Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder associated with premutation alleles of the fragile X mental retardation 1 (FMR1) gene. Approximately 40{\%} of older male premutation carriers, and a smaller proportion of females, are affected by FXTAS; due to the lower penetrance the characterization of the disorder in females is much less detailed. Core clinical features of FXTAS include intention tremor, cerebellar gait ataxia and frequently parkinsonism, autonomic dysfunction and cognitive deficits progressing to dementia in up to 50{\%} of males. In this study, we report the clinical, molecular and neuropathological findings of eight female premutation carriers. Significantly, four of these women had dementia; of the four, three had FXTAS plus dementia. Post-mortem examination showed the presence of intranuclear inclusions in all eight cases, which included one asymptomatic premutation carrier who died from cancer. Among the four subjects with dementia, three had sufficient number of cortical amyloid plaques and neurofibrillary tangles to make Alzheimer's disease a highly likely cause of dementia and a fourth case had dementia with cortical Lewy bodies. Dementia appears to be more common than originally reported in females with FXTAS. Although further studies are required, our observation suggests that in a portion of FXTAS cases there is Alzheimer pathology and perhaps a synergistic effect on the progression of the disease may occur.",
keywords = "Activation ratio, Alzheimer disease, FMR1 premutation, FXTAS, RNA toxicity",
author = "Flora Tassone and Greco, {C. M.} and Hunsaker, {M. R.} and Seritan, {A. L.} and Berman, {Robert F} and Gane, {L. W.} and S. Jacquemont and K. Basuta and Lee-Way Jin and Hagerman, {Paul J} and Hagerman, {Randi J}",
year = "2012",
month = "7",
doi = "10.1111/j.1601-183X.2012.00779.x",
language = "English (US)",
volume = "11",
pages = "577--585",
journal = "Genes, Brain and Behavior",
issn = "1601-1848",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS

AU - Tassone, Flora

AU - Greco, C. M.

AU - Hunsaker, M. R.

AU - Seritan, A. L.

AU - Berman, Robert F

AU - Gane, L. W.

AU - Jacquemont, S.

AU - Basuta, K.

AU - Jin, Lee-Way

AU - Hagerman, Paul J

AU - Hagerman, Randi J

PY - 2012/7

Y1 - 2012/7

N2 - Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder associated with premutation alleles of the fragile X mental retardation 1 (FMR1) gene. Approximately 40% of older male premutation carriers, and a smaller proportion of females, are affected by FXTAS; due to the lower penetrance the characterization of the disorder in females is much less detailed. Core clinical features of FXTAS include intention tremor, cerebellar gait ataxia and frequently parkinsonism, autonomic dysfunction and cognitive deficits progressing to dementia in up to 50% of males. In this study, we report the clinical, molecular and neuropathological findings of eight female premutation carriers. Significantly, four of these women had dementia; of the four, three had FXTAS plus dementia. Post-mortem examination showed the presence of intranuclear inclusions in all eight cases, which included one asymptomatic premutation carrier who died from cancer. Among the four subjects with dementia, three had sufficient number of cortical amyloid plaques and neurofibrillary tangles to make Alzheimer's disease a highly likely cause of dementia and a fourth case had dementia with cortical Lewy bodies. Dementia appears to be more common than originally reported in females with FXTAS. Although further studies are required, our observation suggests that in a portion of FXTAS cases there is Alzheimer pathology and perhaps a synergistic effect on the progression of the disease may occur.

AB - Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder associated with premutation alleles of the fragile X mental retardation 1 (FMR1) gene. Approximately 40% of older male premutation carriers, and a smaller proportion of females, are affected by FXTAS; due to the lower penetrance the characterization of the disorder in females is much less detailed. Core clinical features of FXTAS include intention tremor, cerebellar gait ataxia and frequently parkinsonism, autonomic dysfunction and cognitive deficits progressing to dementia in up to 50% of males. In this study, we report the clinical, molecular and neuropathological findings of eight female premutation carriers. Significantly, four of these women had dementia; of the four, three had FXTAS plus dementia. Post-mortem examination showed the presence of intranuclear inclusions in all eight cases, which included one asymptomatic premutation carrier who died from cancer. Among the four subjects with dementia, three had sufficient number of cortical amyloid plaques and neurofibrillary tangles to make Alzheimer's disease a highly likely cause of dementia and a fourth case had dementia with cortical Lewy bodies. Dementia appears to be more common than originally reported in females with FXTAS. Although further studies are required, our observation suggests that in a portion of FXTAS cases there is Alzheimer pathology and perhaps a synergistic effect on the progression of the disease may occur.

KW - Activation ratio

KW - Alzheimer disease

KW - FMR1 premutation

KW - FXTAS

KW - RNA toxicity

UR - http://www.scopus.com/inward/record.url?scp=84863195737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863195737&partnerID=8YFLogxK

U2 - 10.1111/j.1601-183X.2012.00779.x

DO - 10.1111/j.1601-183X.2012.00779.x

M3 - Article

C2 - 22463693

AN - SCOPUS:84863195737

VL - 11

SP - 577

EP - 585

JO - Genes, Brain and Behavior

JF - Genes, Brain and Behavior

SN - 1601-1848

IS - 5

ER -